Clinical Trials on Relapsed or Refractory Non-Hodgkin Lymphoma
Total 5319 results
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
ImmunityBio, Inc.RecruitingNon Hodgkin's Lymphoma Refractory/RelapsedUnited States
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaboratorsRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30China
-
Shanghai Longyao Biotechnology Inc., Ltd.UnknownNon-Hodgkin Lymphoma | Relapsed and Refractory B Cell LymphomaChina
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Spain, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditionsUnited States, Germany
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Chinese PLA General HospitalRecruitingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsAdvanced Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Refractory Aggressive Non-Hodgkin LymphomaUnited States
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
TakedaActive, not recruitingRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)United States
-
Nationwide Children's HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B Cell Leukemia | B-cell Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Lymphoid Malignancies | Relapsed Non-Hodgkin Lymphoma and other conditionsUnited States
-
Kronos BioRecruitingNon-Hodgkin Lymphoma | Refractory Solid Tumors | Relapsed Solid TumorsUnited States, Spain, United Kingdom
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Relapsed Adult ALL | Relapsed CLL | Refractory B-Cell Small Lymphocytic LymphomaUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineRecruitingHodgkins Lymphoma | Non Hodgkins LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Han weidongRecruitingRelapsed and Refractory B-cell Non-Hodgkin's Lymphoma | Decitabine-primed Tandem CD19/CD20 CAR T CellsChina
-
Spectrum Pharmaceuticals, IncCompletedNon-Hodgkins Lymphoma | Tumors | Hodgkins DiseaseUnited States, Canada
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Peking University Cancer Hospital & InstituteNanjing Legend Biotech Co.RecruitingRelapsed B-cell Non-Hodgkin Lymphoma | Refractory B-cell Non-Hodgkin LymphomaChina
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Adam KittaiRecruitingRecurrent Transformed Non-Hodgkin Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed... and other conditionsUnited States
-
ImmunityBio, Inc.Not yet recruitingNon-Hodgkin Lymphoma Refractory/ Relapsed
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States